Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Rezolute, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 2.21M | 2.37M | +161.7K (+7.3%) |
| Value | $31.6M | $17.6M | −$13.9M (−44.1%) |
New holders (3)
Institutions that held Rezolute, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 35,712 | $265.0K | 0.00% |
| Oppenheimer & Co Inc | 12,281 | $92.0K | 0.00% |
| Wells Fargo & Company | 28 | $0 | 0.00% |
Sold out (1)
Institutions that held Rezolute, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Advisor Group Holdings, Inc. | 65 | $1.00K |